Blonder Tongue Laboratories Statistics
Blonder Tongue Laboratories (BDRLQ) Stock Statistics & Valuation Metrics
Total Valuation
Blonder Tongue Laboratories has a market cap or net worth of $15.00. The enterprise value is $8.09T.
- Market Cap
- $15.00
- Enterprise Value
- $8.09T
Share Statistics
Blonder Tongue Laboratories has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- ―
- Owned by Insiders
- ―
- Owned by Institutions
- 2.26%
Financial Efficiency
Blonder Tongue Laboratories’s return on equity (ROE) is 0.72 and return on invested capital (ROIC) is -10.64%.
- Return on Equity (ROE)
- 0.72
- Return on Assets (ROA)
- -0.13
- Return on Invested Capital (ROIC)
- -10.64%
- Return on Capital Employed (ROCE)
- -0.22
- Revenue Per Employee
- 166.64K
- Profits Per Employee
- -18.63K
- Employee Count
- 67
- Asset Turnover
- 1.18
- Inventory Turnover
- 3.46
Valuation Ratios
The current PE Ratio of Blonder Tongue Laboratories is -0.00. Blonder Tongue Laboratories’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Blonder Tongue Laboratories had revenue of 11.16M and earned -1.25M in profits. Earnings per share was -0.09.
- Revenue
- 11.16M
- Gross Profit
- 3.71M
- Operating Income
- -682.00K
- Pretax Income
- -1.24M
- Net Income
- -1.25M
- EBITDA
- 447.00K
- Earnings Per Share (EPS)
- -0.09
Cash Flow
In the last 12 months, operating cash flow was 1.09M and capital expenditures -89,000, giving a free cash flow of 1.00M billion.
- Operating Cash Flow
- 1.09M
- Free Cash Flow
- 1.00M
- Free Cash Flow per Share
- 0.07
Dividends & Yields
Blonder Tongue Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 35763.65%
- Earnings Yield
- -43225.27%
Stock Price Statistics
- Beta
- 30.79
- 52-Week Price Change
- -33.33%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 48.92
- Average Volume (3m)
- 160.72K
Important Dates
Blonder Tongue Laboratories upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Nov 15, 2023
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Blonder Tongue Laboratories as a current ratio of 0.60, with Debt / Equity ratio of -470.73%
- Current Ratio
- 0.60
- Quick Ratio
- 0.26
- Debt to Market Cap
- 3.95
- Net Debt to EBITDA
- 18.13
- Interest Coverage Ratio
- -0.81
Taxes
In the past 12 months, Blonder Tongue Laboratories has paid 12.00K in taxes.
- Income Tax
- 12.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Blonder Tongue Laboratories EV to EBITDA ratio is 18.14, with an EV/FCF ratio of 7.83.
- EV to Sales
- 0.73
- EV to EBITDA
- 18.14
- EV to Free Cash Flow
- 7.83
- EV to Operating Cash Flow
- 7.80
Balance Sheet
Blonder Tongue Laboratories has $93.00K in cash and marketable securities with $8.17M in debt, giving a net cash position of -$8.08M billion.
- Cash & Marketable Securities
- $93.00K
- Total Debt
- $8.17M
- Net Cash
- -$8.08M
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- -$0.23
Margins
Gross margin is 33.18%, with operating margin of -6.11%, and net profit margin of -11.18%.
- Gross Margin
- 33.18%
- Operating Margin
- -6.11%
- Pretax Margin
- -11.07%
- Net Profit Margin
- -11.18%
- EBITDA Margin
- 4.00%
- EBIT Margin
- -3.56%
